Business Wire

Pathway Genomics to Launch Next-Generation Sequencing (NGS) Comprehensive Cancer Panel Including BRCA1 and BRCA2

SAN DIEGO--(BUSINESS WIRE)--Pathway Genomics, a genetic testing laboratory on the forefront of bringing physicians a broad genetic testing portfolio covering a wide range of diseases, announces the ...
ascopubs.org

Prospective prevalence estimation of BRCA1, BRCA2, and other germline mutations associated with hereditary pancreatic cancer (HPC) using a comprehensive gene panel in an ...

Somatic profiling guides germline genetic testing in patients with mutations in cancer predisposition genes. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does ...
ascopubs.org

Multigene panel testing for hereditary breast and ovarian cancers: An analysis of 1303 BRCA-negative Chinese patients.

Adherence to National Comprehensive Cancer Network Guidelines for BRCA testing among breast cancer patients. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I. This abstract does ...
Jewish Telegraphic Agency

There’s a new test for cancer risks from a longtime Jewish genetic screening program

The comprehensive panel tests for over 60 cancer susceptibility genes associated with hereditary risks for breast, ovarian, prostate, colorectal, skin and other cancers. After discovering a suspicious ...
Reuters

Counsel women with likely BRCA family history: panel

NEW YORK (Reuters Health) - Doctors should screen women with a family history of breast or ovarian cancer to see if the cancers might be due to certain mutations - and if so, women should be counseled ...
Today

Can 23andme detect BRCA gene mutations? What to know before and after testing

Not only do home genetic test kits, like 23andMe, provide information about your ancestry, but they can also give you some insights into your inherited health risks, particularly mutations on the BRCA ...